News Releases

Beckman Coulter, a global leader in clinical diagnostics, announced today that South West London Pathology (SWLP) has implemented DxH 900 haematology analysers and the Early Sepsis Indicator...

Beckman Coulter, Inc., a Danaher company, today announced that it has initially been awarded a contract of $1.25 million, with potential to be awarded an additional $6.5 million if all contract...

Designed for mid-volume laboratories, Beckman Coulter’s DxH 690T offers industry-leading 93% first pass yield, and includes a 5-part differential and the Early Sepsis Indicator Brea, Calif., Oct...

Beckman Coulter, a global leader in clinical diagnostics, announced today that the DxA 5000 total laboratory automation solution has received FDA 510(k) clearance and is now available for sale in...

Beckman Coulter, a global leader in clinical diagnostics, announced today that its small, but mighty DxH 520 hematology analyzer received the Scientists' Choice Award® for Best New Clinical...

Beckman Coulter announced that its MicroScan WalkAway family of instruments has once again received IMV ServiceTrak's "Best System Performance" award in the AST/ID category. ServiceTrak™...

Beckman Coulter today announced that at the 71st Annual AACC conference it will showcase its clinical chemistry, immunoassay, hematology, urinalysis and microbiology solutions, configured in the...

The DxA 5000 delivers rapid and consistent turnaround time, provides the industry’s most comprehensive pre-analytical sample quality assessment and improves laboratory efficiency BREA, Calif....

A major milestone on its strategic mission to lead in sepsis diagnostics, Beckman Coulter today announced that its Early Sepsis Indicator has received 510(k) clearance from the U.S. Food and Drug...

Le dosage Access PCT vient renforcer le plus vaste portefeuille de tests de diagnostic in vitro du secteur pour l'identification et la gestion du sepsis BREA, Californie, 26 mars 2019 /PRNewswire/ --